"The death rattle" in the intensive care unit after withdrawal of mechanical ventilation in neurological patients

Neurocritical Care

Volumn 3, Issue 2, 2005, Pages 107-110

  Kompanje, Erwin J O ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anticholinergic drugs; Death rattle; Ethics; Neurocritical care; Withdrawal of mechanical ventilation

Indexed keywords

ATROPINE; BELLADONNA ALKALOID; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYDROCORTISONE; HYOSCYAMINE; MIDAZOLAM; MORPHINE; SCOPOLAMINE; SCOPOLAMINE BROMIDE;

ARTIFICIAL VENTILATION; BRAIN METASTASIS; BRAIN TUMOR; BRONCHUS MUCOSA; COMA; COUGHING; DEATH; DEATH RATTLE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LUNG CANCER; NEUROLOGIC DISEASE; NOISE; PARENTERAL NUTRITION; POSTURAL DRAINAGE; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SPUTUM; TERMINAL DISEASE;

EUTHANASIA, PASSIVE; HUMANS; LIFE SUPPORT CARE; RESPIRATION, ARTIFICIAL; RESPIRATORY SOUNDS; TERMINAL CARE; UNCONSCIOUSNESS;

EID: 24944560374     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:3:2:107     Document Type: Review

References (19)

1. Morita T, Tsunoda J, Inoue S. Contributing factors to physical symptoms in terminally-ill cancer patients. J Pain Symptom Manage 1999;18:338-346.
2. Wildiers H, Menten J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage 2002;23:310-317.
3. Morita T, Hyodo I, Yoshimi T, et al. Incidence and underlying etiologies of bronchial secretion in terminally ill cancer patients: a multicenter, prospective, observational study. J Pain Symptom Manage 2004;27:533-539.
4. Hughes AC, Wilcock A, Corcoran R. Management of "death rattle". J Pain Symptom Manage 1996;12:271-272.
5. Morita T, Tsunoda J, Inoue S, Chihara S. Risk factors for death rattle in terminally ill cancer patients :a prospective exploratory study. Palliat Med 2000;14:19-23.
6. Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med 2001;15:329-336.
7. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care 1990;7:7-15.
8. Kåss RM, Ellershaw J. Respiratory tract secretions in the dying patient: a retrospective study. J Pain Symptom Manage 2003;26:897-902.
9. Bennett M, Lucas V, Brennan M, Hughes A, O'Donnell V, Wee B. Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care. Palliat Med 2002;16:369-374.
10. Ellershaw JE, Sutcliffe JM, Saunders CM. Dehydration and the dying patient. J Pain Symptom Manage 1995;10:192-197.
11. Curtis JR, Rubenfeld GD, eds. Managing death in the intensive care unit. The transition from cure to comfort. Oxford, Oxford University Press, 2001.
12. Truog RD, Cist AFM, Brackett SE, et al. Recommendations for end-of-life care in the intensive care unit: the Ethics Committee of the Society of Critical Care Medicine. Crit Care Med 2001;29:2332-2348.
13. Carlet J, Thijs LG, Antonelli M, et al. Challenges in end-of-life care in the ICU. Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003. Intensive Care Med 2004;30:770-784.
14. Cook D, Rocker G, Heyland D. Dying in the ICU: strategies that may improve end-of-life care. Can J Anesth 2004;51:266-272.
15. Engström Å, Söderberg S. The experience of partners of critically ill persons in an intensive care unit. Intensive Crit Care Nurs 2004;20:299-308.
16. Pochard F, Azoulay E, Chevret S, et al. Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med 2001;29:1893-1897.
17. Steinhauser KE, Christakis NA, Clipp EC, et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000;284:2476-2482.
18. Voltz R, Bernat JL, Borasio GD, Maddocks I, Oliver D, Portenoy RK, eds. Palliative care in neurology. Oxford, Oxford University Press 2004.
19. Macleod AD. Neurogenic pulmonary edema in palliative care. J Pain Symptom Manage 2002;23:154-156.